Please sign in to follow a disease.

Focal segmental glomerulosclerosis 2

MONDO:0011390

Any focal segmental glomerulosclerosis in which the cause of the disease is a mutation in the TRPC6 gene.

Also known as: FSGS2, TRPC6 focal segmental glomerulosclerosis, focal segmental glomerulosclerosis 2, focal segmental glomerulosclerosis caused by mutation in TRPC6, focal segmental glomerulosclerosis type 2, glomerulosclerosis, focal segmental, 2

2 clinical trials for this condition and its sub-types, 1 tagged with Focal segmental glomerulosclerosis 2 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Inherited focal segmental glomerulosclerosis (4)

Including sub-types (2) Tagged with Focal segmental glomerulosclerosis 2 (1)

Trials to join now! 1

New pill aims to slow kidney damage in FSGS patients

Disease control Recruiting now

This study tests an oral medication called BI 764198 for people with a kidney condition called focal segmental glomerulosclerosis (FSGS). About 286 adults and teens will take either the study drug or a placebo daily for up to 2 years, while continuing their usual FSGS treatments.…

Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC

Focal segmental glomerulosclerosis 2

Where it sits in the disease tree

New pill aims to slow kidney damage in FSGS patients